We use cookies for a better user experience. Read our Privacy Policy

I Agree

Pediatric Growth Hormone Deficiency Market

Pediatric Growth Hormone Deficiency Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Pediatric Growth Hormone Deficiency Market: Introduction

Pediatric growth hormone is one of the key factors for children’s growth and it is produced by the pituitary gland. This growth hormone is necessary for normal growth and development as it stimulates cell reproduction and regeneration in both children and adults. Growth hormone is circulated throughout the body via the bloodstream to assist with a variety of activities and functions. Growth hormone deficiency can be partial or total and can occur in infancy or during childhood. Approximately one in 4,000 to 10,000 children have growth hormone deficiency.

Pituitary gland is linked to the hypothalamus and is located near the base of the brain. Therefore, if the pituitary gland or hypothalamus is damaged, the production rate of growth hormone is reduced; affecting the kid’s height and development. This deficiency can also be caused due to some genetic changes or mutations in DNA.

Child could exhibit symptoms such as short stature, a chubby body, a young-looking face, and late or no puberty if the growth hormone is deficient. Treatment of childhood growth hormone deficiency involves replacing the body's growth hormone with injections. Treatment can be given daily or several times a week. Serious side effects of these injections are rare but could include headaches, fluid retention, body pain, and hip pain. Early diagnosis and treatment can help a number of children with growth hormone deficiency maximize their potential adult height.

Key Factors and Developments in Pediatric Growth Hormone Deficiency Market

  • The pediatric growth hormone deficiency market is driven by the development of recombinant growth hormone drugs, a rise in number of pituitary dysfunction cases, and increase in off-label use of human growth hormone
  • Key players in the pediatric growth hormone deficiency market are focusing on the pen form of injection (solvent drugs), as they are easy to use and less time-consuming than the powder form of drugs. Parents of pediatric patients are also preferring the liquid form of drugs. The powder form of growth hormone is comparatively risky for children.
  • Growth hormone deficiency is a rare disorder that primarily affects children. The recombinant form of a growth hormone, Somatotropin, is generally prescribed to treat pediatric patients with growth hormone deficiency. Somatotropin is a growth hormone injection that is commonly prescribed for the treatment of Turner syndrome, short stature, Prader-Willi syndrome, Noonan syndrome and other disorders. In pediatric patients with GH deficiency, Recombinant 22KDa GH is injected once daily via subcutaneous route, mainly in the evening time.
  • The COVID-19 pandemic has had a significant impact on global health and security. According to the article published in the Frontiers in Endocrinology Journal in November 2020, patients with decreased growth hormone secretion were at a higher risk for COVID-19 severity and required more preventive measures. Patients with Prader-Willi syndrome also need extra care to minimize the risk.

North America to Capture Major Share of Global Pediatric Growth Hormone Deficiency Market

  • North America dominated the global pediatric growth hormone deficiency market with a market share of US$ 448 Mn in 2020. Growth deficiency disorder is estimated to affect 1 in 3,500 in the U.S. Most companies are producing and selling drugs which are primarily in solvent form. The market in Canada is expanding due to the presence of advanced healthcare facilities.
  • Germany is likely to gain market share due to increase in adoption of advanced growth hormone therapies by a number of medical centers
  • Asia Pacific held a market share of US$ 419 Mn in 2020 due to rising demand for powder form of growth hormone powder form. As per the report by the Australian Pediatric Endocrine Group, 25-50 out of 100,000 girls are born with Turner Syndrome every year.

Key players operating in Pediatric Growth Hormone Deficiency Market

Major players operating in the pediatric growth hormone deficiency treatment market are listed below:

  • Novo Nordisk A/S
  • Eli Lily and Company
  • Novartis AG,
  • Merck KGaA,
  • Pfizer Inc.
  • Ferring B.V
  • Genentech
  • BioParteners GmbH
  • LG Chem Ltd.
  • Ipsen Pharma

Global Pediatric Growth Hormone Deficiency Market Research Scope:

Global Pediatric Growth Hormone Deficiency Market, by Type

  • Congenital GH Deficiency
  • Acquired GH Deficiency
  • Idiopathic GH Deficiency

Global Pediatric Growth Hormone Deficiency Market, by Product

  • Powder
  • Solvent

Global Pediatric Growth Hormone Deficiency Market, by Application

  • Growth Hormone Deficiency
  • Idiopathic Short Stature
  • Turner Syndrome
  • Small for Gestational Age
  • Prader-Willi Syndrome
  • Others

Global Pediatric Growth Hormone Deficiency Market, by Drug

  • Genotropin
  • Humatrope
  • Norditropin FlexPro
  • Others

Global Pediatric Growth Hormone Deficiency Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Global Pediatric Growth Hormone Deficiency Market, by Region

  • North America
    • U S
    • Canada
  • Europe
    • Germany
    • Italy
    • United Kingdom
    • Spain
    • Remaining Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Remaining Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

284

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved